PACB FY 2007 Earnings Report — Pacific Biosciences of California, Inc. Revenue & Financial Results | Market Cap Arena

Pacific Biosciences of California, Inc.PACB

FY 2007 Earnings

Reported December 30, 2007

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2007	Prior Q	FY 2006	QoQ Change	YoY Change
Revenue	$2M	—	—	—	—
Op. Income	-$23M	—	—	—	—
Gross Margin	100.0%	—	—	—	—
Net Margin	-994.8%	—	—	—	—
EPS (Diluted)	$-27.81	—	—	—	—
Free Cash Flow	-$20M	—	—	—	—

Income Statement

Item	Amount
REVENUE	$2M
Cost of Revenue	$0
GROSS PROFIT	$2M
R&D Expenses	$19M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$6M
Other Expenses	-$67.0K
Operating Expenses	$26M
Cost & Expenses	$26M
OPERATING INCOME	-$23M
Interest Income	$2M
Interest Expense	$0
Other Income/Expenses	$2M
INCOME BEFORE TAX	-$22M
Income Tax Expense	$0
Net Income from Continuing Ops	-$22M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	-$22M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	-$22M
D&A	$2M
EBIT	-$23M
EBITDA	-$22M
EPS	-$28
EPS Diluted	-$28

Cash Flow Statement

Item	Amount
Net Income	-$22M
Depreciation & Amortization	$2M
Stock-Based Compensation	$2M
Deferred Income Tax	$10.0K
Other Non-Cash Items	-$88.0K
Change in Working Capital	$2M
OPERATING CASH FLOW	-$17M
Capital Expenditure	-$3M
Acquisitions (Net)	$0
Purchases of Investments	-$54M
Sales/Maturities of Investments	$39M
Other Investing Activities	$0
NET CASH FROM INVESTING	-$18M
Net Debt Issuance	-$392.0K
Common Stock Repurchased	-$5.0K
Common Dividends Paid	$0
Other Financing Activities	$172.0K
NET CASH FROM FINANCING	-$225.0K
FREE CASH FLOW	-$20M
Net Change in Cash	-$35M